• USFDA approves new indication for valve repair device by Abbott biospectrumasia
    March 18, 2019
    The U.S. Food and Drug Administration has approved a new indication for a heart valve repair device that is intended to reduce moderate-to-severe or severe mitral regurgitation, a leakage of blood backward through the mitral valve into the heart’s left at
PharmaSources Customer Service